Lazarus, Hillard M.
Allogeneic Stem Cell Transplantation
1. Allogeneic Stem Cell Transplantation: The Last Century
John M. Goldman
2. Full Intensity and Reduced Intensity Allogeneic Transplantation in AML
Charles Craddock
3. Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL)
Bella Patel, Anthony H. Goldstone, Adele K. Fielding
4. Hematopoietic Progenitor Cell Transplantation for Treatment of Chronic Lymphocytic Leukemia
Leslie A. Andritsos, John C. Byrd, Steven M. Devine
5. The Role of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients in the Era of Tyrosine Kinase Inhibitors
Richard T. Maziarz
6. Allogeneic Transplantation for Hodgkin’s Lymphoma
William Broderick, Patrick Stiff
7. Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
J. Kuruvilla, P. Mollee, J. H. Lipton
8. Non-Hodgkin’s Lymphoma: Allogeneic Reduced Intensity Conditioning
Sonali M. Smith, Ginna G. Laport
9. The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults
Heidi D. Klepin, David D. Hurd
10. Single Versus Tandem Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma
David H. Vesole
11. Treatment Strategies for Follicular Center Cell Non-Hodgkin’s Lymphoma
Frank Heinzelmann, Hellmut Ottinge, Claus Belka
12. The Role of Transplantation in Favorable-Risk Acute Myeloid Leukemia
Mickey Liao, Gary J. Schiller
13. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults
David I. Marks
14. Allogeneic Transplantation for Myelodysplastic Syndromes
Geoffrey L. Uy, John F. DiPersio
15. Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
Adriana Balduzzi, Lucia Maio, Mary Eapen, Vanderson Rocha
16. Allogeneic Transplantation for the Treatment of Multiple Myeloma
Rebecca L. Olin, Dan T. Vogl, Edward A. Stadtmauer
17. Blood Vs. Marrow Allogeneic Stem Cell Transplantation
Brian McClune, Daniel Weisdorf
18. Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors
Ephraim J. Fuchs, Heather J. Symons
19. Unrelated Donor Transplants
A Bacigalupo
20. Update on Umbilical Cord Blood Transplantation
Karen Ballen
21. Selection of Cord Blood Unit(s) for Transplantation
Donna A. Wall, Ka Wah Chan
22. Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation
Steven M. Devine
23. Natural Killer-Cell Based Treatment in Hematopoetic Stem Cell Transplantation
Martin Stern, Sandrine Meyer-Monard, Uwe Siegler, Jakob R. Passweg
24. Cryopreservation of Allogeneic Stem Cell Products
Noelle V. Frey, Steven C. Goldstein
25. Concepts and Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation
Steven C. Goldstein, Selina Luger
26. Allogeneic Haematopoietic Stem Cell Transplantation and Natural Killer Cell Alloreactivity
Franco Aversa, Andrea Velardi
27. Therapeutic Potential of Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation
Luis A. Solchaga, Hillard M. Lazarus
28. Hematopoietic Stem Cell Transplantation for Thalassemia
Javid Gaziev, Guido Lucarelli
29. Viral Infections in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman
30. Fungal Infections
John R. Wingard
31. Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation
Kirsten M. Williams, Ronald E. Gress
32. Acute Graft Versus Host Disease: Prophylaxis
Corey Cutler, Vincent T. Ho, Joseph H. Antin
33. Chronic Graft-Versus-Host Disease
Madan Jagasia, Steven Pavletic
34. Post-transplant Lymphoproliferative Disorder
Ran Reshef, Alicia K. Morgans, Donald E. Tsai
35. Psychological Care of Adult Allogeneic Transplant Patients
Flora Hoodin, Felicity W. K. Harper, Donna M. Posluszny
36. Second Allogeneic Transplantation: Outcomes and Indications
Koen Besien, Dan Pollyea, Andrew Artz
37. Minimal Residual Disease
Mehmet Uzunel
38. Functional Assessment Tools and Co-morbidity Scoring in Hematopoietic Progenitor Cell Transplantation
Sergio Giralt, Uday Popat
39. Unique Thrombotic and Hemostatic Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantation
Amber A. Petrolla, Hillard M. Lazarus, Alvin H. Schmaier
40. How Much Isolation Is Enough for Allografts?
Brandon Hayes-Lattin
41. Monoclonal Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Maria Corinna Palanca-Wessels, Oliver Press
42. Treatment of Acute Graft-vs-Host Disease
Steven C. Goldstein, Sophie D. Stein, David L. Porter
43. The Importance of Non-Human Primate Models for Pre-clinical Studies in Hematopoiesis
Erzsebet Szilagyi, Nadim Mahmud, Amelia Bartholomew
44. In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation
Lisbeth A. Welniak, William J. Murphy
45. Dendritic Cells
Jacalyn Rosenblatt, David Avigan
46. Augmentation of Hematopoietic Stem Cell Transplantation with Anti-cancer Vaccines
Edward D. Ball, Peter R. Holman
47. Erratum To
Flora Hoodin, Felicity W. K. Harper, Donna M. Posluszny
Nyckelord: Medicine & Public Health, Hematology
- Författare
- Lazarus, Hillard M.
- Laughlin, Mary J.
- Utgivare
- Springer
- Utgivningsår
- 2010
- Språk
- en
- Utgåva
- 1
- Serie
- Contemporary Hematology
- Sidantal
- 902 sidor
- Kategori
- Hälsa, skönhet, mode
- Format
- E-bok
- eISBN (PDF)
- 9781597454780